Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Sankyo will seek FDA approval for temocapril HCl in 1997

June 28, 1996

Neurex seeks FDA approval for Corlopam

June 28, 1996

Endothelin antagonists in Kyowa Hakko's pipeline

June 28, 1996

Angiotensin II antagonists described by Sankyo

June 28, 1996

Roberts' ProAmatine approaches FDA approval

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

L-arginine is effective in heart failure patients

June 21, 1996

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...